President of the jury

Diogo José Fernandes Homem de Lucena

Diogo José Fernandes Homem de Lucena was born in Lisbon, on 8 March 1949. He is an Electrical Engineer by the Instituto Superior Técnico (1972), with a Master of Science (1976) and a Ph.D. (1978) by the Stanford University.

 

Throughout his academic career he has collaborated with the Instituto Superior Técnico and the Economics Faculty of the Universidade Nova de Lisboa, in which he is a Cathedrated Professor (retired). He was also a Visiting Professor in the Stanford University.

 

His main areas of interest were centred, first, in the Uncertainty and Information Economics and in the Telecommunications Economy, and, afterwards, in the matters of the Welfare State Economics, particularly the financing of Health, Education and Social Security.

 

He was part of the Installing Commission the Economics Faculty of the Universidade Nova de Lisboa, where he was MBA Program Director, President of the Pedagogical, Scientific and Councils and Director. He was a member of the Installing Commission of the Law Faculty of the same University, where he was also the Vice-Dean. He was the President of the Scientific Council of the Social and Human Sciences at the Foundation for Science and Technology. He is a member of the National Education Council.

 

He was elected Academic Correspondent of the Lisbon Sciences Academy, in 2007.

 

He was a consultant and participated in the Advisory Councils of several public and private institutions. He participated in the social organs of various companies and foundations, namely as a Member of the Calouste Gulbenkian Foundation’s Management Board, between January 1999 and January 2014. He is member of the Aljubarrota Foundation’s Directive Council. He is part of the juries for the Pessoa Prize.                                                                                                   


Amílcar Falcão

Amílcar Falcão holds a degree in Pharmaceutical Sciences, PhD and Aggregate in Pharmacy (Pharmacology Specialty) from the University of Coimbra. Full Professor, he is starting 1st of March 2019 Dean of the Coimbra University.

 

It has an extensive scientific productivity where there are about 400 publications (articles, book chapters and summaries in indexed journals) and other scientific communications in the form of posters and oral presentations (several dozen by invitation), overwhelmingly international and subject arbitration. He was the thesis supervisor of 15 master's and 8 doctoral students, and is currently responsible for 9 doctoral theses and 3 master's theses. He is regularly invited to perform the function of reviewer, also belonging to the editorial staff of several scientific journals. He has already received several national and international awards that reinforce the visibility and quality of the work he has been developing throughout his career.

 

Having maintained a strong connection with the pharmaceutical industry throughout his professional career, his collaboration with BIAL Laboratories (Portugal) stands out, participating actively and in a relevant way in his program of development of new medicines. Its contribution is to both non-clinical and clinical trials (biostatistics, pharmacokinetics and pharmacodynamics) and has been involved in more than a hundred studies in total. Included in the portfolio are a set of molecules with special emphasis on Eslicarbazepine Acetate, which was the first Portuguese drug to be marketed (Zebinix®) and, more recently, Opicapone (new medicine for Parkinson's disease, currently in Phase III).


Ana Paula Martins

Ana Paula Martins Silvestre Correia holds a degree in Pharmaceutical Sciences from the Faculty of Pharmacy of the University of Lisbon in 1990. She completed her Masters in Epidemiology at the Faculty of Medical Sciences of the Nova University of Lisbon in 1995 and her Ph.D. in Clinical Pharmacy at the Faculty of Pharmacy of Lisbon in May 2005.


She is, since February 2016, president of the Portuguese Pharmaceutical Society. She is an assistant professor of the Faculty of Pharmacy of the University of Lisbon in the Department of Socio-Pharmacy.

 

She has dozens of articles published in national and international journals and participated as author and co-author in chapters of books in the area of Pharmacoepidemiology. Two of her areas of interest are monitoring the safety of new drugs and in the field of comparative effectiveness in Oncology.


She is currently leading Lisbon, Santarém and Setubal Pharmacovigilance Units. 


She was Chairperson of the Board of the Lisbon Regional General Assembly of the Order of Pharmacists, Member of the Board of the Portuguese Epidemiology Association and President of the Portuguese Society of Clinical Pharmacy and Pharmacotherapy. She was a member of the Health Technology Assessment Task Force of the European Federation Pharmaceutical Industries and Associations (EFPIA) representing APIFARMA. She is a member of the Board of the Portuguese Association of Epidemiology, of the Pharmaceutical Sciences Portugal Academy and ‘Membre Correspondant Étranger’ of Académie Nationale de Pharmacie (France) and she is also member of Portuguese Society of Pharmacology.

Helena GarridoHelena Garrido is a journalist, deputy director of information at RTP (Rádio e Televisão de Portugal) and Professor of Economics Journalism at the Lusófona University of Humanities and Technologies. She began her career as a journalist in 1987. She is graduated in Economics from the Faculty of Economics of the Nova University of Lisbon.


Jorge Moreira Gonçalves

Jorge Moreira Gonçalves is Professor of Pharmacology at the Faculty of Pharmacy of the University of Porto (U.Porto).


He graduated in Pharmaceutical Sciences from the Faculty of Pharmacy of the U. Porto, having a PhD in 1991, at the same University, in Pharmacology. As a postdoctoral fellow, he was a fellow of the Alexander von Humboldt Foundation at the Institut für Pharmakologie und Toxikologie, Universität Freiburg.


His scientific areas of interest are cellular communication, specializing in neurotransmission, immunity and cancer. His scientific production is published internationally in scientific articles and book chapters, published in the main scientific journals of his area of expertise. He is also an Investigator at Institute of Health Investigation and Innovation of the University of Porto (U. Porto).


He was director of the Laboratory of Pharmacology of the Faculty of Pharmacy of U.Porto, Director of this Faculty between 2002 and 2005 and Vice-Dean of University of Porto for Investigation, Innovation and Development (2006-2014). Within these functions, he was one of the leading heads of the creation of the Science and Technology Park of University of Porto as well as the implementation of the Pole of the Sea and Agrário de Vairão Campus. He was also responsible for the promotion of the student’s integration program in graduated projects of scientific investigation (IJUP).


He coordinated the initiative of the Calouste Gulbenkian Foundation, "Noroeste Global" in 2014 and 2015, which merged the community of the innovation of North of Portugal in role of one strategy of knowledge transference.

José Eduardo Soares Moniz

José Eduardo Soares Moniz de Lucena was born in Ponta Delgada on May 6, 1952.

 

Academic training:

 

• Secondary School: National High School of Ponta Delgada

 

• Degree: German Philology, Faculty of Arts of the University of Lisbon

 

• Frequency of seminars abroad

Miguel Gouveia

Miguel Gouveia is Professor in the Catholic Lisbon School of Business and Economics. He received his Ph.D. in Economics from the University of Rochester after a degree in Economics from the Portuguese Catholic University. He teaches in the areas of Health Economics, Economic Analysis of Social Policies and Public Economy. He was a consultant to the World Bank and several public and private institutions in Portugal. He was a member of the Commission on the White Paper on Social Security, Chairman of the Evaluation Committee of Hospitals SA and coordinated the working group that made the assessment of the budgetary impact of the creation of Family Health Units. Has published research in the area of Health Economics with emphasis on the economic evaluation of health technologies.

Paulo Barradas Rebelo

Paulo Barradas Rebelo holds a degree in Pharmaceutical Sciences from the Faculty of Pharmacy of the University of Coimbra in 1993. Graduated in Pharmaceutical Management from Catholic University of Portugal in 2001 and INSEAD's M&As and a Corporate Strategy program in 2013.

 

He was Technical Director and Owner of Pharmacy in the Centro Region of Portugal for 10 years and President’s Direction of Farbeira – Corporative of Center’s Pharmaceutical, CRL and Manager of Farmoeste - Distribuidora Farmacêutica do Oeste, Lda. from 1998 to 2001.

 

In 2001, he led a group of professionals who founded Bluepharma – Pharmaceutical Industry, S.A. and acquired the manufacturing facilities of the multinational Bayer in Coimbra. It stood out for the role played in the company's turn-around process, actively contributing to the maintenance of a technology-based strategic sector in Portugal, with an increase in the number of employees, market share and improved profitability.

 

Bluepharma was the first pharmaceutical company in Portugal to obtain the triple integrated certification in Quality, Environment, Occupational Health and Safety and is also certified by EMAS and the Food and Drug Administration (FDA). Its investments in Innovation, Investment, Internationalization and Quality have also been recognized with several prizes, the most recent being the COTEC-BPI SME Innovation Award 2012, the Insead Entrepreneurship Award 2012, Portugal Ventures' Oustanding Venture of the Year 2013 and the PME Excellence Award 2013. As a result of the partnership with the University of Coimbra, Bluepharma launched spin-offs - Luzitin, SA, Treat U, SA and BSim2, Lda.

Paulo Duarte

Paulo Jorge Cleto Duarte is pharmaceutical, entrepreneur and co-owner of Estacio Pharmacy and Estacio Xabregas Pharmacy, both in Lisbon.

 

He is President of the Nacional Association Board of Pharmacies, since 2013.

 

Since may 2017, he is a member of the National Health Council – Government advisory.

 

He has been President of the Board of the European Pharmacist Forum (EPF), sponsored by Walgreens Boots Alliance, since December 2017.

 

He began his professional career in Pharmaceutical Industry at Johnson & Johnson.

 

He was Technical Secretary of the Portugal’s National Commission Against AIDS, where he collaborated with Professor Maria Odette Santos Ferreira.

 

He was General Secretary of the Portuguese Pharmaceutical Society, General Secretary of the National Association of Pharmacies and General Secretary of the Association of Pharmacists of Portuguese Speaking Countries (AFPLP).

 

In 1997, Paulo Cleto took a degree in Pharmaceutical Pharmacy at Faculty of Pharmacy of Lisbon. He holds an MBA in Information Management from Faculty of Economics Science of Catholic University of Portugal (2004).

Paulo Gonçalves

Paulo Gonçalves is a Partner at BCG (The Boston Consulting Group) since 2011 and is currently responsible for Health in Iberia. He joined BCG in 2001 in the Lisbon office and from 2005 to 2010 he was in the Madrid office. Since 2011 he has been in Barcelona, being responsible for the local BCG office across Europe.

 

Its activity in the area of Health develops in different sectors, from the pharmaceutical company, to the patient associations, through the activity of health care and the distribution of drugs at the warehouse and pharmacy level. During the 18 years of experience in Health Consultancy, he has developed more than 230 projects for the sector, covering different themes with concrete experience in designing and supporting the implementation of innovative marketing and market access mechanisms for pharmaceutical products and services as well as in the evaluation and support to the decision of investment in different situations. In his experience there are also some projects in the area of specialized and general retail.

Rogério Gaspar

Rogério Gaspar is a Full Professor of the Faculty of Pharmacy of the University of Lisbon (FFUL).

 

He also serves as Vice-President of the European Federation for Pharmaceutical Sciences, president of the Portuguese Society of Pharmaceutical Sciences, member of the coordination of the Portuguese Observatory on Health Systems, president of the School Council and Social Pharmacy Department of the Faculty of Pharmacy, University of Lisbon. He also holds positions at the Directorate of the Institute for Bioengineering and Biosciences at Higher Technical Institute, University of Lisbon.

 

He was Vice-Dean of the University of Lisbon, between 2013 and 2016. Before, he was Sub-Director of School of Arts and Humanities of the University of Lisbon (since September 2012 with the investigation and international relations area responsibility) as well as member of the Scientific Council and Assembly of Faculty. Between 2008 and 2013, he was member of the General Council of University of Lisbon.

 

He has a degree in Pharmaceutical Science (specialized in Industrial Pharmacy – July 1985), he took a PhD in Pharmaceutical Science (Université Catholique de Louvain, June 1991) and he is affiliated in Pharmacy in University of Coimbra (January 1999). His academics career was developed in University of Coimbra (1985-2006), Catholic University of Louvaina (where he took is PhD. between 1987 and 1991) and Lisbon (since February 2006).